Literature DB >> 15866726

Characterisation of tyrosine-phosphorylation-defective calmodulin mutants.

Valentina Salas1, Juan Sánchez-Torres, David M Cusidó-Hita, Yael García-Marchan, Felipe Sojo, Gustavo Benaim, Antonio Villalobo.   

Abstract

Using site-directed mutagenesis, we have produced three calmodulin (CaM) mutants in which one or the two tyrosine residues of native CaM were substituted by phenylalanine. The three variants, denoted CaM(Y99F), CaM(Y138F), and CaM(Y99F/Y138F), were highly expressed in transformed Escherichia coli BL21(DE3)pLysS and purified in high yield. The three CaM mutants were able to activate the cyclic nucleotide phosphodiesterase and the plasma membrane Ca(2+)-ATPase, and present the characteristic Ca(2+)-induced electrophoretic mobility shift of native CaM. CaM(Y138F) and CaM(Y99F/Y138F), however, showed a slightly higher electrophoretic mobility than CaM(Y99F) or wild type CaM. The molar extinction coefficient of native CaM at 276 nm decreases 50% in CaM(Y99F) and CaM(Y138F), while the 276nm peak disappears in CaM(Y99F/Y138F). Terbium fluorescence studies with the different CaM mutants indicate that Y99 (but not Y138) closely interacts with Ca(2+) in the III Ca(2+)-binding domain. The epidermal growth factor receptor (EGFR) and the non-receptor tyrosine kinase c-Src phosphorylate CaM(Y99F) and CaM(Y138F) at a lesser extent than wild type CaM, while they fail to phosphorylate CaM(Y99F/Y138F) as expected. All resulting phospho-(Y)CaM species present the characteristic Ca(2+)-induced electrophoretic mobility shift observed in non-phosphorylated CaM. Quantitative analysis of the different phospho-(Y)CaM species suggests that the relative phosphorylation of Y99 and Y138 in wild type CaM by both the EGFR and c-Src is different than the respective phosphorylation of either Y99 in CaM(Y138F) or Y138 in CaM(Y99F).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866726     DOI: 10.1016/j.pep.2005.01.004

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).

Authors:  Kaiyu Yuan; Gu Jing; Jianfeng Chen; Hui Liu; Kui Zhang; Yuebin Li; Hui Wu; Jay M McDonald; Yabing Chen
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

2.  Significance of calcium binding, tyrosine phosphorylation, and lysine trimethylation for the essential function of calmodulin in vertebrate cells analyzed in a novel gene replacement system.

Authors:  Svetlana Panina; Alexander Stephan; Jonas M la Cour; Kivin Jacobsen; Line K Kallerup; Rasita Bumbuleviciute; Kristoffer V K Knudsen; Pablo Sánchez-González; Antonio Villalobo; Uffe H Olesen; Martin W Berchtold
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

3.  Characterization of phospho-(tyrosine)-mimetic calmodulin mutants.

Authors:  Silviya R Stateva; Valentina Salas; Gustavo Benaim; Margarita Menéndez; Dolores Solís; Antonio Villalobo
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

4.  Ca2+/Calmodulin and Apo-Calmodulin Both Bind to and Enhance the Tyrosine Kinase Activity of c-Src.

Authors:  Silviya R Stateva; Valentina Salas; Estefanía Anguita; Gustavo Benaim; Antonio Villalobo
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

Review 5.  The multifunctional role of phospho-calmodulin in pathophysiological processes.

Authors:  Antonio Villalobo
Journal:  Biochem J       Date:  2018-12-21       Impact factor: 3.857

Review 6.  Disruption of Intracellular Calcium Homeostasis as a Therapeutic Target Against Trypanosoma cruzi.

Authors:  Gustavo Benaim; Alberto E Paniz-Mondolfi; Emilia Mia Sordillo; Nathalia Martinez-Sotillo
Journal:  Front Cell Infect Microbiol       Date:  2020-02-14       Impact factor: 5.293

Review 7.  Calmodulin: The switch button of calcium signaling.

Authors:  Chiu-Fen Yang; Wen-Chin Tsai
Journal:  Tzu Chi Med J       Date:  2021-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.